{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:49:34Z","timestamp":1790401774433,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022811","name":"Fondazione Nadia Valsecchi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007368","name":"Fondazione Pisa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.drup.2026.101408","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:19:01Z","timestamp":1777583941000},"page":"101408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance"],"prefix":"10.1016","volume":"87","author":[{"given":"Benoit","family":"Immordino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5410-8841","authenticated-orcid":false,"given":"Mafalda Angelica","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Comandatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahrou","family":"Vahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-9556","authenticated-orcid":false,"given":"Luca","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-7504","authenticated-orcid":false,"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2026.101408_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/cells10040816","article-title":"GSK-3\u03b2 can regulate the sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 breast cancer cells to chemotherapeutic drugs, targeted therapeutics and nutraceuticals","volume":"10","author":"Abrams","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drup.2026.101408_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jcm6010005","article-title":"The TGF-\u03b2\/Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance","volume":"6","author":"Ahmed","year":"2017","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.drup.2026.101408_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-017-0448-5","article-title":"The role of stromal cancer-associated fibroblasts in pancreatic cancer","volume":"10","author":"von Ahrens","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib4","unstructured":"American Cancer Society Cancer Facts & Figures 2025; Atlanta, GA, 2025;"},{"key":"10.1016\/j.drup.2026.101408_bib5","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1038\/s41598-022-07004-x","article-title":"KRAS Gene Mutation Quantification in the Resection or Venous Margins of Pancreatic Ductal Adenocarcinoma Is Not Predictive of Disease Recurrence","volume":"12","author":"Amintas","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2026.101408_bib6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/01.MP.0000087422.24733.62","article-title":"Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases with and 152 Cases without Pancreatic Ductal Adenocarcinoma","volume":"16","author":"Andea","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.drup.2026.101408_bib7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/onc.2013.57","article-title":"AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells","volume":"33","author":"Asiedu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib8","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.18632\/oncotarget.2422","article-title":"Axl as a mediator of cellular growth and survival","volume":"5","author":"Axelrod","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2026.101408_bib9","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1136\/gutjnl-2021-325272","article-title":"Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6\/AXL signalling axis","volume":"71","author":"Bellomo","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.drup.2026.101408_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2014.10.010","article-title":"A prospective randomised phase-ii trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV","volume":"51","author":"Bergmann","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.drup.2026.101408_bib12","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.drup.2026.101408_bib13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/cancers17071152","article-title":"Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth","volume":"17","author":"Bye","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101408_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","article-title":"An epithelial\u2013mesenchymal transition gene signature predicts resistance to egfr and pi3k inhibitors and identifies axl as a therapeutic target for overcoming EGFR inhibitor resistance","volume":"19","author":"Byers","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2026.101408_bib15","first-page":"145","article-title":"Preclinical Development of Mecbotamab Vedotin (BA3011), a Novel, AXL-Specific Conditional Active Biologic Antibody\u2013Drug Conjugate","volume":"8","author":"Chang","year":"2025","journal-title":"Antib. Ther."},{"key":"10.1016\/j.drup.2026.101408_bib16","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15140","article-title":"AXL Targeting by a Specific Small Molecule or Monoclonal Antibody Inhibits Renal Cell Carcinoma Progression in an Orthotopic Mice Model","volume":"9","author":"Chen","year":"2021","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.drup.2026.101408_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12929-018-0465-x","article-title":"AXL Phosphorylates and Up-Regulates TNS2 and Its Implications in IRS-1-Associated Metabolism in Cancer Cells","volume":"25","author":"Cheng","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drup.2026.101408_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.oraloncology.2015.04.004","article-title":"Polarization of Tumor-Associated Macrophages and Gas6\/Axl Signaling in Oral Squamous Cell Carcinoma","volume":"51","author":"Chiu","year":"2015","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103659","article-title":"\u201cDepart from Evil, and Do Good\u201d: Turning Axl from Uncontrolled Tumorigenic Gene to Biomarker for Early Detection of Pancreatic Cancer","volume":"173","author":"Comandatore","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.drup.2026.101408_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2017.07.001","article-title":"A Mechanopharmacology Approach to Overcome Chemoresistance in Pancreatic Cancer","volume":"31","author":"Coppola","year":"2017","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2026.101408_bib21","doi-asserted-by":"crossref","unstructured":"Cruz, V.H.; Arner, E.N.; Du, W.; Bremauntz, A.E.; Brekken, R.A. Axl-Mediated Activation of TBK1 Drives Epithelial Plasticity in Pancreatic Cancer. JCI Insight 4, e126117, doi:10.1172\/jci.insight.126117.","DOI":"10.1172\/jci.insight.126117"},{"key":"10.1016\/j.drup.2026.101408_bib22","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/s41388-019-0803-9","article-title":"Tumor-Associated Macrophage-Secreted 14-3-3\u03b6 Signals via AXL to Promote Pancreatic Cancer Chemoresistance","volume":"38","author":"D\u2019Errico","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139576","article-title":"Macrophage AXL Receptor Tyrosine Kinase Inflames the Heart after Reperfused Myocardial Infarction","volume":"131","author":"DeBerge","year":"2021","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2026.101408_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40262-012-0027-4","article-title":"Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies","volume":"52","author":"Dostalek","year":"2013","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.drup.2026.101408_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14728222.2018.1527315","article-title":"Does Axl Have Potential as a Therapeutic Target in Pancreatic Cancer?","volume":"22","author":"Du","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.drup.2026.101408_bib26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1158\/1541-7786.MCR-20-0860","article-title":"AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer","volume":"19","author":"Du","year":"2021","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib27","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.3390\/ijms21228419","article-title":"AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations","volume":"21","author":"Falcone","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101408_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-023-01467-9","article-title":"GAS6-Based CAR-T Cells Exhibit Potent Antitumor Activity against Pancreatic Cancer","volume":"16","author":"Fan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature17630","article-title":"TAM Receptors Regulate Multiple Features of Microglial Physiology","volume":"532","author":"Fourgeaud","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101408_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody Drug Conjugate: The \u201cBiological Missile\u201d for Targeted Cancer Therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.drup.2026.101408_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.trecan.2023.01.003","article-title":"Antibody\u2013Drug Conjugates: In Search of Partners of Choice","volume":"9","author":"Fuentes-Antr\u00e1s","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nri.2017.48","article-title":"Immunosuppressive Cell Death in Cancer","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2026.101408_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113604","article-title":"The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression","volume":"42","author":"Goyette","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101408_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2026.101408_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved Survival with Ipilimumab in Patients with Metastatic Melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2026.101408_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.canlet.2008.04.017","article-title":"Receptor Tyrosine Kinase AXL Is Induced by Chemotherapy Drugs and Overexpression of AXL Confers Drug Resistance in Acute Myeloid Leukemia","volume":"268","author":"Hong","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101408_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41586-024-08225-y","article-title":"Clinical Functional Proteomics of Intercellular Signalling in Pancreatic Cancer","volume":"637","author":"Huang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101408_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113067","article-title":"AXL-Initiated Paracrine Activation of pSTAT3 Enhances Mesenchymal and Vasculogenic Supportive Features of Tumor-Associated Macrophages","volume":"42","author":"Hung","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.drup.2026.101408_bib39","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-07-0862","article-title":"Axl and Growth Arrest-Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme","volume":"14","author":"Hutterer","year":"2008","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fimmu.2020.00297","article-title":"Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis","volume":"11","author":"Ireland","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.drup.2026.101408_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5958\/0974-360X.2021.00100.1","article-title":"A Comprehensive Review on Pancreatic Cancer","volume":"14","author":"Jagadeesan","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.drup.2026.101408_bib42","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The Role of Microenvironment in Tumor Angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI85610","article-title":"Inhibition of the GAS6\/AXL Pathway Augments the Efficacy of Chemotherapies","volume":"127","author":"Kariolis","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2026.101408_bib44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nchembio.1636","article-title":"An Engineered Axl \u201cdecoy Receptor\u201d Effectively Silences the Gas6-Axl Signaling Axis","volume":"10","author":"Kariolis","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.drup.2026.101408_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/PAS.0000000000002245","article-title":"PanIN or IPMN? Redefining Lesion Size in 3 Dimensions","volume":"48","author":"Kiemen","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.drup.2026.101408_bib46","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1158\/0008-5472.CAN-14-2887-T","article-title":"Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis","volume":"75","author":"Kirane","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101408_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic Cancer: A Review of Current Treatment and Novel Therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest Surg."},{"key":"10.1016\/j.drup.2026.101408_bib48","doi-asserted-by":"crossref","first-page":"28766","DOI":"10.1074\/jbc.M401977200","article-title":"Hydrogen Peroxide Activates the Gas6-Axl Pathway in Vascular Smooth Muscle Cells","volume":"279","author":"Konishi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101408_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00423-008-0282-x","article-title":"Morphogenesis of Pancreatic Cancer: Role of Pancreatic Intraepithelial Neoplasia (PanINs)","volume":"393","author":"Koorstra","year":"2008","journal-title":"Lange Arch. Surg."},{"key":"10.1016\/j.drup.2026.101408_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4161\/cbt.8.7.7923","article-title":"The Axl Receptor Tyrosine Kinase Confers an Adverse Prognostic Influence in Pancreatic Cancer and Represents a New Therapeutic Target","volume":"8","author":"Koorstra","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.drup.2026.101408_bib51","doi-asserted-by":"crossref","unstructured":"Krebs, N.; Klein, L.; Wegwitz, F.; Espinet, E.; Maurer, H.C.; Tu, M.; Penz, F.; K\u00fcffer, S.; Xu, X.; Bohnenberger, H.; et al. Axon Guidance Receptor ROBO3 Modulates Subtype Identity and Prognosis via AXL-Associated Inflammatory Network in Pancreatic Cancer. JCI Insight 7, e154475, doi:10.1172\/jci.insight.154475.","DOI":"10.1172\/jci.insight.154475"},{"key":"10.1016\/j.drup.2026.101408_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/cas.12171","article-title":"Cisplatin Influences Acquisition of Resistance to Molecular-Targeted Agents through Epithelial-Mesenchymal Transition-like Changes","volume":"104","author":"Kurokawa","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2026.101408_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-019-0377-8","article-title":"Targeting of the AXL Receptor Tyrosine Kinase by Small Molecule Inhibitor Leads to AXL Cell Surface Accumulation by Impairing the Ubiquitin-Dependent Receptor Degradation","volume":"17","author":"Lauter","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.drup.2026.101408_bib54","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1158\/1078-0432.CCR-16-1316","article-title":"Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis","volume":"23","author":"Leconet","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib55","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/onc.2013.487","article-title":"Preclinical Validation of AXL Receptor as a Target for Antibody-Based Pancreatic Cancer Immunotherapy","volume":"33","author":"Leconet","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib56","doi-asserted-by":"crossref","first-page":"a009076","DOI":"10.1101\/cshperspect.a009076","article-title":"Biology of the TAM Receptors","volume":"5","author":"Lemke","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.drup.2026.101408_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13073-020-00776-9","article-title":"Single-Cell Transcriptome Analysis of Tumor and Stromal Compartments of Pancreatic Ductal Adenocarcinoma Primary Tumors and Metastatic Lesions","volume":"12","author":"Lin","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.drup.2026.101408_bib58","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1073\/pnas.85.6.1952","article-title":"Transforming Genes in Chronic Myelogenous Leukemia","volume":"85","author":"Liu","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101408_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-024-02210-9","article-title":"AXL: Shapers of Tumor Progression and Immunosuppressive Microenvironments","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib60","article-title":"NF-\u03baB Signaling in Inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.drup.2026.101408_bib61","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1182\/blood-2009-06-228684","article-title":"Malignant Cells Fuel Tumor Growth by Educating Infiltrating Leukocytes to Produce the Mitogen Gas6","volume":"115","author":"Loges","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.drup.2026.101408_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1516419","article-title":"Antibody-drug conjugates in cancer therapy: applications and future advances","volume":"16","author":"Long","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2026.101408_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13046-019-1153-8","article-title":"Therapeutic Challenges and Current Immunomodulatory Strategies in Targeting the Immunosuppressive Pancreatic Tumor Microenvironment","volume":"38","author":"Looi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/0008-5472.CAN-17-1973","article-title":"Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer","volume":"78","author":"Ludwig","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib65","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.clinbiochem.2004.05.006","article-title":"Tyrosine Kinase Inhibitors in Cancer Therapy","volume":"37","author":"Madhusudan","year":"2004","journal-title":"Clin. Biochem"},{"key":"10.1016\/j.drup.2026.101408_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/gm430","article-title":"Pancreatic Cancer Genomics: Insights and Opportunities for Clinical Translation","volume":"5","author":"Makohon-Moore","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.drup.2026.101408_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103797","article-title":"Soluble AXL Is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis","volume":"75","author":"Mart\u00ednez-Bosch","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2026.101408_bib68","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/MPA.0000000000000786","article-title":"The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma","volume":"46","author":"Matsuda","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.drup.2026.101408_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic Targeting of the Functionally Elusive TAM Receptor Family","volume":"23","author":"Miao","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2026.101408_bib70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1158\/2159-8290.CD-15-0933","article-title":"Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance","volume":"6","author":"Miller","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101408_bib71","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ijc.30180","article-title":"Antibody-mediated Neutralization of Autocrine Gas6 Inhibits the Growth of Pancreatic Ductal Adenocarcinoma Tumors in Vivo","volume":"139","author":"Moody","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib72","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.3390\/cancers16223825","article-title":"An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas","volume":"16","author":"Moris","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101408_bib73","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM Receptors): Implications for Macrophages in the Tumor Microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib74","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biologicals.2022.08.006","article-title":"ADCC Enhancement: A Conundrum or a Boon to mAb Therapy?","volume":"79","author":"Narvekar","year":"2022","journal-title":"Biologicals"},{"key":"10.1016\/j.drup.2026.101408_bib75","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pharmthera.2015.08.006","article-title":"State of the Art and Future Directions of Pancreatic Ductal Adenocarcinoma Therapy","volume":"155","author":"Neuzillet","year":"2015","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.drup.2026.101408_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From State-of-the-Art Treatments to Novel Therapies for Advanced-Stage Pancreatic Cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib77","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CLC.2009.n.039","article-title":"Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non\u2013Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway","volume":"10","author":"Nguyen","year":"2009","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib78","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1074\/jbc.270.2.551","article-title":"The Transforming Receptor Tyrosine Kinase, Axl, Is Post-Translationally Regulated by Proteolytic Cleavage","volume":"270","author":"O\u2019Bryan","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101408_bib79","first-page":"5016","article-title":"a Transforming Gene Isolated from Primary Human Myeloid Leukemia Cells, Encodes a Novel Receptor Tyrosine Kinase","volume":"11","author":"O\u2019Bryan","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.drup.2026.101408_bib80","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/s41388-023-02810-7","article-title":"AXL Activates YAP through the EGFR\u2013LATS1\/2 Axis and Confers Resistance to EGFR-Targeted Drugs in Head and Neck Squamous Cell Carcinoma","volume":"42","author":"Okamoto","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib81","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-19-2321","article-title":"ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer","volume":"26","author":"Okura","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.694","article-title":"Mechanisms of Resistance to Tyrosine Kinase Inhibitor-targeted Therapy and Overcoming Strategies","volume":"5","author":"Ou","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2026.101408_bib83","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.drup.2026.101408_bib84","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191937","article-title":"Early Neoplastic Lesions of the Pancreas: Initiation, Progression, and Opportunities for Precancer Interception","volume":"135","author":"Pedro","year":"2025","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.drup.2026.101408_bib85","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41401-022-01047-6","article-title":"AXL Antibody and AXL-ADC Mediate Antitumor Efficacy via Targeting AXL in Tumor-Intrinsic Epithelial-Mesenchymal Transition and Tumor-Associated M2-like Macrophage","volume":"44","author":"Pei","year":"2023","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.drup.2026.101408_bib86","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13058-025-02015-8","article-title":"AXL Promotes Inflammatory Breast Cancer Progression by Regulating Immunosuppressive Macrophage Polarization","volume":"27","author":"Phi","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.drup.2026.101408_bib87","doi-asserted-by":"crossref","DOI":"10.3892\/or.2020.7689","article-title":"Modulation of Protein S and Growth Arrest Specific 6 Protein Signaling Inhibits Pancreatic Cancer Cell Survival and Proliferation","author":"Pilli","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2026.101408_bib88","first-page":"340","article-title":"The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates","volume":"13","author":"Poruk","year":"2013","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.drup.2026.101408_bib89","series-title":"Textbook of Pancreatic Cancer: Principles and Practice of Surgical Oncology","first-page":"357","article-title":"Clinical Presentation and Symptoms in Pancreatic Cancer","author":"Primavesi","year":"2021"},{"key":"10.1016\/j.drup.2026.101408_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114324","article-title":"AXL\/GAS6 Signaling Governs Differentiation of Tumor-Associated Macrophages in Breast Cancer","volume":"444","author":"Purohit","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2026.101408_bib91","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101408_bib92","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.27492","article-title":"Axl Activates Autocrine Transforming Growth Factor-\u03b2 Signaling in Hepatocellular Carcinoma","volume":"61","author":"Reichl","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.drup.2026.101408_bib93","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1016\/j.ejca.2013.06.041","article-title":"Maintenance Sunitinib or Observation in Metastatic Pancreatic Adenocarcinoma: A Phase II Randomised Trial","volume":"49","author":"Reni","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2026.01.001","article-title":"Emerging landscape of KRAS inhibitors in cancer treatment","volume":"44","author":"Riedl","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2026.101408_bib95","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/cancers14040985","article-title":"Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment","volume":"14","author":"Robatel","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101408_bib96","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101408_bib97","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic Adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.drup.2026.101408_bib98","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T Cell Engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101408_bib99","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/cancers12082274","article-title":"Mechanisms of T-Cell Exhaustion in Pancreatic Cancer","volume":"12","author":"Saka","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101408_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.811247","article-title":"The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges","volume":"12","author":"Sang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic Ductal Adenocarcinoma: Treatment Hurdles, Tumor Microenvironment and Immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib102","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT Signaling in Inflammation and Stress-Related Diseases: Implications for Therapeutic Interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.drup.2026.101408_bib103","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1078-0432.CCR-15-1458","article-title":"Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy","volume":"22","author":"Scaltriti","year":"2016","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib104","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody Therapy of Cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114253","article-title":"Structure-Based Discovery of Receptor Tyrosine Kinase AXL Degraders with Excellent Anti-Tumor Activity by Selectively Degrading AXL and Inducing Methuosis","volume":"234","author":"Shi","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.drup.2026.101408_bib106","first-page":"4529","article-title":"Research Progress on the PI3K\/AKT Signaling Pathway in Gynecological Cancer (Review)","volume":"19","author":"Shi","year":"2019","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.drup.2026.101408_bib107","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1593\/neo.05640","article-title":"Expression of Axl in Lung Adenocarcinoma and Correlation with Tumor Progression","volume":"7","author":"Shieh","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.drup.2026.101408_bib108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/cncr.25483","article-title":"Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma","volume":"117","author":"Song","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib109","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.drup.2026.101408_bib110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers14010217","article-title":"The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy","volume":"14","author":"Sturm","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101408_bib111","series-title":"Proceedings of the Featured Posters: Poster Rounds with the Professors","first-page":"A70.3","article-title":"PR070\/#391 Phase I Trial of Tilvestamab, a Function-Blocking Antibody Inhibiting AXL, in Platinum-Resistant\/Refractory High Grade Serous Ovarian Cancer (PROC)","author":"Tan","year":"2023"},{"key":"10.1016\/j.drup.2026.101408_bib112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00423-024-03577-5","article-title":"Analyzing the High Frequency of False-Positive Carcinoembryonic Antigen Elevations in Postoperative Pancreatic Ductal Adenocarcinoma","volume":"410","author":"Tanaka","year":"2024","journal-title":"Lange Arch. Surg."},{"key":"10.1016\/j.drup.2026.101408_bib113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semcancer.2012.02.013","article-title":"EMT as the Ultimate Survival Mechanism of Cancer Cells","volume":"22","author":"Tiwari","year":"2012","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.drup.2026.101408_bib114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the Performance of Macrophages in Tumour Microenvironment: A Call for Precision Immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of Precision Cancer Medicine: Evolution of the Treatment Paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.drup.2026.101408_bib116","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12943-019-0953-y","article-title":"Axl Kinase Drives Immune Checkpoint and Chemokine Signalling Pathways in Lung Adenocarcinomas","volume":"18","author":"Tsukita","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib117","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/15257770.2024.2319215","article-title":"Pharmacological Mechanisms Underlying the Interaction of the Nucleoside Analogue Gemcitabine with the C-MET Inhibitor Tivantinib in Pancreatic Cancer","volume":"43","author":"Vahabi","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.drup.2026.101408_bib118","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.3390\/ijms23147493","article-title":"Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma","volume":"23","author":"Van Renterghem","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2026.101408_bib119","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/imr.13265","article-title":"Antibody-mediated Phagocytosis in Cancer Immunotherapy","volume":"319","author":"Van Wagoner","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.drup.2026.101408_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105278","article-title":"Hallmarks of Pancreatic Cancer: Spotlight on TAM Receptors","volume":"107","author":"V\u00e1zquez-Bell\u00f3n","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.drup.2026.101408_bib121","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.7150\/thno.15083","article-title":"Gas6\/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt\/GSK-3\u03b2\/\u03b2-Catenin Signaling","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2026.101408_bib122","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.21037\/tcr.2019.09.61","article-title":"Blockade of AXL Activation Overcomes Acquired Resistance to EGFR Tyrosine Kinase Inhibition in Non-Small Cell Lung Cancer","volume":"8","author":"Wang","year":"2019","journal-title":"Transl. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/1535-7163.MCT-20-0316","article-title":"EMT-Induced Gemcitabine Resistance in Pancreatic Cancer Involves the Functional Loss of Equilibrative Nucleoside Transporter 1","volume":"20","author":"Weadick","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101408_bib124","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cellimm.2018.05.004","article-title":"A Novel AXL Chimeric Antigen Receptor Endows T Cells with Anti-Tumor Effects against Triple Negative Breast Cancers","volume":"331","author":"Wei","year":"2018","journal-title":"Cell Immunol."},{"key":"10.1016\/j.drup.2026.101408_bib125","doi-asserted-by":"crossref","first-page":"a026070","DOI":"10.1101\/cshperspect.a026070","article-title":"P53 in the DNA-Damage-Repair Process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.drup.2026.101408_bib126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13046-023-02868-x","article-title":"Antibody Drug Conjugates: Hitting the Mark in Pancreatic Cancer?","volume":"42","author":"Wittwer","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2026.101408_bib127","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/cancers13071521","article-title":"The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications","volume":"13","author":"Wium","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2026.101408_bib128","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1038\/onc.2010.268","article-title":"An Anti-Axl Monoclonal Antibody Attenuates Xenograft Tumor Growth and Enhances the Effect of Multiple Anticancer Therapies","volume":"29","author":"Ye","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/1535-7163.MCT-21-0293","article-title":"AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2026.101408_bib130","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ng.2330","article-title":"Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1016\/j.drup.2026.101408_bib131","article-title":"The Immunoregulation Effect of Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.drup.2026.101408_bib132","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK Signal Pathways in the Regulation of Cell Proliferation in Mammalian Cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"10.1016\/j.drup.2026.101408_bib133","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of Genetic and Epigenetic Alterations of CDKN2A (P16(INK4a)) in Cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.drup.2026.101408_bib134","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/onc.2015.343","article-title":"Targeting MET and AXL Overcomes Resistance to Sunitinib Therapy in Renal Cell Carcinoma","volume":"35","author":"Zhou","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101408_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic Cancer-Targeting Exosomes for Enhancing Immunotherapy and Reprogramming Tumor Microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2026.101408_bib136","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL Receptor Tyrosine Kinase as a Promising Anti-Cancer Approach: Functions, Molecular Mechanisms and Clinical Applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101408_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113620","article-title":"NAT10-Mediated AXL mRNA N4-Acetylcytidine Modification Promotes Pancreatic Carcinoma Progression","volume":"428","author":"Zong","year":"2023","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.drup.2026.101408_bib138","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/biomedicines13040844","article-title":"Novel mRNA-Engineered Fully Human CAR-T Cells Targeting AXL in Solid Tumors","volume":"13","author":"Zou","year":"2025","journal-title":"Biomedicines"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:22:10Z","timestamp":1783192930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":138,"alternative-id":["S1368764626000592"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101408","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of AXL in pancreatic cancer: Biomarker potential and therapeutic targeting to counteract drug resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101408"}}